ROMANO, ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 3.350
AS - Asia 468
EU - Europa 302
AF - Africa 4
OC - Oceania 4
SA - Sud America 2
Totale 4.130
Nazione #
US - Stati Uniti d'America 3.345
CN - Cina 245
SG - Singapore 153
IT - Italia 95
FI - Finlandia 55
VN - Vietnam 41
GB - Regno Unito 34
SE - Svezia 31
DE - Germania 26
FR - Francia 20
IN - India 9
IE - Irlanda 7
NL - Olanda 7
TR - Turchia 7
UA - Ucraina 7
CA - Canada 5
RU - Federazione Russa 5
CZ - Repubblica Ceca 4
ES - Italia 4
NZ - Nuova Zelanda 4
TW - Taiwan 4
HK - Hong Kong 3
JP - Giappone 3
DK - Danimarca 2
EG - Egitto 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
AR - Argentina 1
BE - Belgio 1
BR - Brasile 1
ET - Etiopia 1
HU - Ungheria 1
IR - Iran 1
LU - Lussemburgo 1
ZA - Sudafrica 1
Totale 4.130
Città #
Fairfield 609
Woodbridge 354
Houston 268
Chandler 261
Ashburn 248
Cambridge 234
Seattle 224
Ann Arbor 202
Wilmington 198
Singapore 128
Boardman 65
San Diego 62
Santa Clara 54
Beijing 51
Princeton 48
Dong Ket 41
Medford 38
Des Moines 37
Jacksonville 35
Roxbury 33
Helsinki 32
Padova 32
Nanjing 31
Dearborn 18
Guangzhou 17
Shenyang 13
New York 12
Falls Church 11
Hefei 11
Nanchang 11
Cologno Monzese 8
Hebei 8
Shanghai 8
Dublin 7
Bologna 6
Cagliari 6
Zhengzhou 6
Jinan 5
Kunming 4
Paris 4
Taizhou 4
Wuhan 4
Yenibosna 4
Amsterdam 3
Changsha 3
Chicago 3
Detroit 3
Hong Kong 3
Jiaxing 3
Kaohsiung City 3
Ketsch 3
Kilburn 3
Los Angeles 3
Pune 3
Taiyuan 3
Tianjin 3
Tokyo 3
Toronto 3
Banská Štiavnica 2
Cairo 2
Chengdu 2
Chiswick 2
Dallas 2
Frankfurt am Main 2
Hackney 2
Hangzhou 2
Istanbul 2
Las Vegas 2
London 2
Majadahonda 2
Milan 2
Monza 2
Ningbo 2
Pavia 2
Peshawar 2
Udine 2
Wandsworth 2
Washington 2
Aarhus 1
Aksum 1
Ankara 1
Auckland 1
Baotou 1
Bari 1
Borås 1
Brendola 1
Brussels 1
Casoria 1
Changchun 1
Chongqing 1
Dunedin 1
Esslingen am Neckar 1
Forlì 1
Fuzhou 1
Girona 1
Hamilton 1
Hounslow 1
Indiana 1
Inverness 1
Johannesburg 1
Totale 3.559
Nome #
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 169
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 159
Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. 150
Prognostic Evaluation of the Donor Risk Index Among a Prospective Cohort of Italian Patients Undergoing Liver Transplantation 147
Newly diagnosed Hepatocellular Carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study 143
Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies. 129
New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine? 127
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 122
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis 122
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 119
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 117
Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis. 115
Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome 110
Progression of hepatocellular carcinoma before liver transplantation: dropout or liver transplantation? 109
Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study. 107
Why and how to measure renal function in patients with liver disease 106
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure 106
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 106
Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites. 105
Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. 101
The liver: Another organ involved in Muir Torre syndrome? 101
Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae 100
Reply to: "A cut-off serum creatinine value of 1.5 mg/dl for AKI--to be or not to be". 98
Terlipressin given by continuous i.v. infusion versus i.v. boluses in the treatment of hepatorenal syndrome: A randomized controlled study. 98
Prospective validation of a new priority allocation model for liver transplant candidates: an interim analysis. 96
Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections. 91
Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation 88
How to improve care in outpatients with cirrhosis and ascites: A new model of care coordination by consultant hepatologists. 83
Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis 83
Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis 83
Assessment of bone mineral density in patients with cirrhosis treated with third-generation nucleos(t)ide analogues: comparison between tenofovir and entecavir 78
Garlic extract prevents CCl4-induced liver fibrosis in rats: The role of tissue transglutaminase 73
Coffee reduces liver damage in a rat model of steatohepatitis: The underlying mechanisms and the role of polyphenols and melanoidins 73
The liver: Another organ involved in Muir Torre syndrome? 72
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis: results of a randomized controlled clinical trial 71
Relapse after direct-acting antivirals (DAAs) in cirrhotic patients with hepatitis C is highly related to development of liver cancer 71
Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure 69
Natural history of acute kidney disease in patients with cirrhosis 62
Bacterial infections in cirrhosis: epidemiology and prevalence of antibiotic resistence, a restrospective monocentric study 50
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: Clinical and virological outcomes 48
Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae: the last therapeutic challenge. 45
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis. 42
Hepatocarcinoma in chronic viral hepatitis: from epidemiological data, through new pathophysiological findings, up to new possible clinical tools 32
miRNA Expression and HCC Occurrence in HCV Cirrhotic Patients Treated with Direct Acting Antivirals 15
Totale 4.191
Categoria #
all - tutte 15.770
article - articoli 15.279
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.049


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020506 0 0 0 0 0 0 132 97 106 87 55 29
2020/2021698 35 43 28 41 26 43 34 54 73 151 96 74
2021/2022717 16 87 97 41 42 35 71 77 50 11 60 130
2022/2023509 96 61 13 66 64 85 1 30 62 2 28 1
2023/2024246 10 38 31 30 21 29 20 17 3 10 20 17
2024/2025373 3 88 56 55 117 54 0 0 0 0 0 0
Totale 4.191